Journal of Gastric Cancer

The Korean Gastric Cancer Association (대한위암학회)
권호 표지

Treatment of Gastric Epithelial Dysplasia That Is Diagnosed by Endoscopic Biopsy

내시경 겸자 생검으로 진단된 위점막 이형성증의 치료 방침

  • Kim, Eun-Young (Department of Surgery, Incheon St. Mary's Hospital The Catholic University of Korea, School of Medicine) ;
  • Kim, Jin-Jo (Department of Surgery, Incheon St. Mary's Hospital The Catholic University of Korea, School of Medicine) ;
  • Kim, Byung-Wuk (Department of Gastroenterology, Incheon St. Mary's Hospital The Catholic University of Korea, School of Medicine) ;
  • Park, Seung-Man (Department of Surgery, Incheon St. Mary's Hospital The Catholic University of Korea, School of Medicine)
  • 김은영 (가톨릭대학교 의과대학 인천성모병원 외과학교실) ;
  • 김진조 (가톨릭대학교 의과대학 인천성모병원 외과학교실) ;
  • 김병욱 (가톨릭대학교 의과대학 인천성모병원 소화기내과학교실) ;
  • 박승만 (가톨릭대학교의과대학 인천성모병원 외과학교실)
  • Received : 2010.01.29
  • Accepted : 2010.03.30
  • Published : 2010.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Gastric epithelial dysplasia (GED) was defined as "unequivocally neoplastic epithelium that may be associated with or give rise to invasive adenocarcinoma" and GED also represents a direct precursor of intestinal type adenocarcinoma of the stomach. The recommended treatment guidelines for GED in the medical literature are endoscopic mucosal resection (EMR) or surgery for high grade dysplasia (HGD) and annual endoscopic surveillance with biopsy for low grade dysplasia (LGD) The aim of this study was to determine the treatment plan for GED that is diagnosed by endoscopic biopsy. Materials and Methods: We enrolled 148 patients who were treated by endoscopic mucosal resection (EMR) or endoscopiccsubmucosal dissection (ESD) for GED: there were 63 patients with HGD and 85 patients with LGD and all of them were diagnosed by endoscopic biopsy from January 2006 to December 2008. The results of the final histopathologic reports after EMR or ESD were compared with the results of the endoscopic biopsies. Results: The final histopathologic results of the 148 patients with GED showed 49 (33.1%) patients with adenocarcinoma, 40 (27.0%) patients with HGD and 59 (39.9%) patients with LGD. Among the 63 patients with HGD, 34 (54.0%) patients had adenocarcinoma, 20 (31.7%) patients had HGD and 9 (14.3%) patients had LGD. For the 85 patients with LGD, 15 (17.6%) patients had adenocarcinoma, 20 (23.5%) patients had HGD and 50 (58.8%) patients had LGD Conclusion: Complete resection, including EMR or ESD, is needed for patients with GED diagnosed by endoscopic biopsy and they have HGD. For patients with LGD, EMR or ESD may be needed in addition to endoscopic surveillance with biopsy for making the correct diagnosis and proper treatment because of the possibility of adenocarcinoma.

목적: 위점막 이형성증은 "위선암과 연관이 있거나 침습성 위선암으로 발전할 가능성이있는 명백한 종양성 상피"로정의되고 있으며 만성위염에서의 암 발생기전에서도 전암성 병변으로 여겨지고 있다. 이에 저자들은 내시경 겸자 생검에서 위점막 이형성증으로 진단된 환자에 대한 적절 한 치료방침을 결정하고자 본 연구를 시행하였다. 대상 및 방법: 2006년 1월부터 2008년 12월까지 3년 동안 내시경 겸자 생검으로 위점막 이형성증으로 진단받고 내시경 점막절제 또는 내시경 점막하 박리술을 시행한 148예를 대상으로 하였으며 내시경 겸자 생검 결과와 최종 조직병리 결과를 비교하였다. 결과: 148예의 환자 중 고도 이형성증 63예, 저도 이형성증 85예였으며 최종 병리 결과 위선암 49예(33.8%), 고도이형성증 40예(27.0%), 저도 이형성증 59예(39.9%)였다. 고도 이형성증으로 진단된 63예는 최종 조직병리 결과 위선암34예(54.0%), 고도 이형성증 20예(31.7%), 저도 이형성증 9예(14.3%)였으며 저도 이형성증으로 진단된 85예는 위선암 15예(17.6%), 고도이형성증 20예(23.5%), 저도이형성증 50예(58.8%)였다.결론: 내시경 겸자 생검 결과 위점막 이형성증으로 진단된 경우 고도 이형성증의 경우는 내시경을 이용한 점막절제 또는 점막하 박리술을 통한 절제술을 시행하고 저도이형성증의 경우 주기적인 감시 및 재생검 뿐 아니라 정확한 진단을 위한 내시경 점막절제 등이 고려되어야 할것이다.

Keywords

References

  1. Ming SC, Bajtai A, Correa P, Elster K, Jarvi OH, Munos N, Nakayo K, Stemmerman GN. Gastric dysplasia: significance and pathologic criteria. Cancer 1984;54:1794-1801. https://doi.org/10.1002/1097-0142(19841101)54:9<1794::AID-CNCR2820540907>3.0.CO;2-W
  2. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988;48:3554-3560.
  3. Lauwers GY, Srivastava A. Gastric preneoplastic lesion and epithelial dysplasia. Gastroenterol Clin N Am 2007;36:813- 829. https://doi.org/10.1016/j.gtc.2007.08.008
  4. Kim H, Jin SY, Jang JJ, Kim WH, Song SY, Kim KR, Yu ES, Shin HS, Kim HK, Sohn JH, et al. Grading system for gastric epithelial proliferative diseases standardized guidelines proposed by Korean study group for pathology of digestive diseases. Korean J Pathol 1997;31:389-400.
  5. Goldstein NS, Lewin KJ. Gastric epithelial dysplasia and adenoma: historical review and histological criteria for grading. Hum Pathol 1997;28:127-133. https://doi.org/10.1016/S0046-8177(97)90095-2
  6. Schemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, Dixon MF, Fengolio-Preiser CM, Flejou JF, Geboas K, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-255. https://doi.org/10.1136/gut.47.2.251
  7. Zhang Y. Typing and grading of gastric dysplasia. In: Zhang Y, Kawai K, eds. Precancerous Conditions and Lesions of the Stomach. Berlin: Springer-Verlag, 1993:64-84.
  8. Oehlert W, Keller P, Henke M, Strauch M. Gastric mucosal dysplasia: what is its clinical significance? Front Gastrointest Res 1979;4:173-182.
  9. Bajtai A, Hidvegi J. The role of gastric mucosal dysplasia in the development of gastric carcinoma. Pathol Oncol Res 1998;4:297-300. https://doi.org/10.1007/BF02905220
  10. Rugge M, Cassaro M, Di Mario F, Leo G, Leandro G, Russo VM, Pennelli G, Farinati F; Interdisciplinary Group on Gastric Epithelial Dysplasia (IGGED). The long term outcome of gastric non-invasive neoplasia. Gut 2003;52:1111-1116. https://doi.org/10.1136/gut.52.8.1111
  11. Di Gregorio C, Morandi P, Fante R, De Gaetani C. Gastric dysplasia. A follow-up study. Am J Gastroenterol 1993;88: 1714-1719.
  12. Hasuike N, Oda I, Gotoda T, Hamanaka H, Yamaguchi H, Kozu T, Matsuda N, Saito D, Shimoda T. Clinical management of gastric adenoma, from the point of view of endoscopic surveillance. Stomach and Intestine 2003;38:1419-1426.
  13. Hansson LE, Lindgren A, Nyren A. Can endoscopic biopsy specimens be used for reliable Laurén classification of gastric cancer? Scand J Gastroenterol 1996;31:711-715. https://doi.org/10.3109/00365529609009155
  14. Namieno T, Koito K, Higashi T, Shimamura T, Yamashita K, Sato N, Kondo Y. Assessing the suitability of gastric carcinoma for limited resection: histologic differentiation of endoscopic biopsy. World J Surg 1998;22:865-868. https://doi.org/10.1007/s002689900483
  15. Park HK, Cheon YK, Jung HK, Park HJ, Cho JY, Cheon GJ, Jung IS, Kim JO, Lee JS, Jin SY, et. al. The study of pathologic difference between endoscopic biopsy before EMR and histology of specimen after endoscopic mucosal resection (EMR) on gastric flat adenoma or early gastric cancer (EGC). Korean J Gastrointest Endosc 2001;23:431-436.
  16. Shon JH, Bae HK, Cho KB, Kwon DY, Park KS, Hwang JS, Huh JW, Ahn SH, Park SK. Histological comparison of endoscopic biopsy with endoscopic eesection in gastric adenoma. Korean J Gastrointest Endosc 2001;23:363.
  17. Kim YD, Cho JY, Jung IS, Koh BM, Hong SJ, Ryu CB, Kim JO, Lee JS, Lee MS, Jin SY, et. al. Comparison of endoscopic forcep biopsy and the histopathologic diagnosis after endoscopic submucosal dissection. Korean J Gastrointest Endosc 2009;38:188-192.
  18. Takahashi H, Fujisaki J, Kamiyama T, Ishiyama A, Yamamoto Y, Hosaka N, Fujita R, Kato H, Muto T. Treatment strategy for gastric adenoma based in cases with long-term follow-up and endoscopic resection-from the point of active resection. Stomach and Intestine 2003;38:1411-1418.
  19. Hwang JY, Park KS, Hwang JS, Ahn JS, Park SK. Histological comparison of endoscopic forceps biopsy with endoscopic resection in gastric mucosal elevated lesion. Korean J Gastrointest Endosc 2003;26:68-72.